Delivered-To: sometime5858@gmail.com
Received: by 10.31.165.138 with SMTP id o132csp2137990vke;
        Tue, 29 Mar 2016 17:33:59 -0700 (PDT)
X-Received: by 10.55.71.135 with SMTP id u129mr6533756qka.26.1459298039398;
        Tue, 29 Mar 2016 17:33:59 -0700 (PDT)
Return-Path: <N.Bakota@nucleusnetwork.com.au>
Received: from mail1.bemta8.messagelabs.com (mail1.bemta8.messagelabs.com. [216.82.243.197])
        by mx.google.com with ESMTP id 77si1386964qgf.22.2016.03.29.17.33.26;
        Tue, 29 Mar 2016 17:33:59 -0700 (PDT)
Received-SPF: neutral (google.com: 216.82.243.197 is neither permitted nor denied by best guess record for domain of N.Bakota@nucleusnetwork.com.au) client-ip=216.82.243.197;
Authentication-Results: mx.google.com;
       spf=neutral (google.com: 216.82.243.197 is neither permitted nor denied by best guess record for domain of N.Bakota@nucleusnetwork.com.au) smtp.mailfrom=N.Bakota@nucleusnetwork.com.au
Return-Path: <N.Bakota@nucleusnetwork.com.au>
Received: from [216.82.242.131] by server-5.bemta-8.messagelabs.com id 9F/87-24561-0DE1BF65; Wed, 30 Mar 2016 00:33:20 +0000
X-Env-Sender: N.Bakota@nucleusnetwork.com.au
X-Msg-Ref: server-4.tower-76.messagelabs.com!1459297503!37931870!16
X-Originating-IP: [59.167.118.49]
X-StarScan-Received:
X-StarScan-Version: 8.11; banners=nucleusnetwork.com.au,-,-
X-VirusChecked: Checked
Received: (qmail 22225 invoked from network); 30 Mar 2016 00:33:18 -0000
Received: from mail.nucleusnetwork.com.au (HELO PRNEX2010.nucleus.local) (59.167.118.49)
  by server-4.tower-76.messagelabs.com with SMTP; 30 Mar 2016 00:33:18 -0000
Received: from PRNEX2010.nucleus.local ([::1]) by PRNEX2010.nucleus.local
 ([::1]) with mapi id 14.02.0318.004; Wed, 30 Mar 2016 11:26:38 +1100
From: Natalie Bakota <N.Bakota@nucleusnetwork.com.au>
Subject: Help make breast cancer medication more affordable & accessible
Thread-Topic: Help make breast cancer medication more affordable & accessible
Thread-Index: AQHRiY0GSYhirCOTtU+8rmPMgTr/Vp9xFnfwgAAL0ZCAAAAoEA==
Date: Wed, 30 Mar 2016 00:26:36 +0000
Message-ID: <43607F02F7F979429DE2661B9FCBF6DFB5EDF140@PRNEX2010.nucleus.local>
Accept-Language: en-AU, en-US
Content-Language: en-US
X-MS-Has-Attach: yes
X-MS-TNEF-Correlator:
x-originating-ip: [192.168.101.21]
Content-Type: multipart/related;
	boundary="_004_43607F02F7F979429DE2661B9FCBF6DFB5EDF140PRNEX2010nucleu_";
	type="multipart/alternative"
MIME-Version: 1.0
X-TUID: OnX+5yYru8Wb

--_004_43607F02F7F979429DE2661B9FCBF6DFB5EDF140PRNEX2010nucleu_
Content-Type: multipart/alternative;
	boundary="_000_43607F02F7F979429DE2661B9FCBF6DFB5EDF140PRNEX2010nucleu_"

--_000_43607F02F7F979429DE2661B9FCBF6DFB5EDF140PRNEX2010nucleu_
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

Hello Everyone

Here is a new study and a very important one.
Although the study may not seem as appealing to you because it requires 8 =
outpatient visits, we believe in the cause as hundreds of thousands of wom=
en still die each year from breast cancer and the currently available drug=
 used to treat some of the breast and/or gastric cancers is very expensive=
 and therefore inaccessible to some women.



If you are interested in participating in the study then please send us a =
return email or contact us on 1800 243 733 as we will need to phone screen=
 you and organise a screening appointment (medical check up).

Please note that we will be screening participants from Thursday 31st Marc=
h to Monday 4th April

YOU NEED TO CALL/EMAIL TO MAKE AN APPOINTMENT. NO WALK-INS.


TZ-01-003:  Breast and gastric cancers are two of the biggest causes of de=
ath from cancer in Australia and worldwide. Trastuzumab, which is marketed=
 in Australia and nearly worldwide as Herceptin(r), has been considerably =
successful in treating these life-threatening conditions over the last 15 =
years. Although not a cure in itself, it has been shown to substantially s=
low the cancer growth and thereby extend the lives of cancer sufferers.

This study is investigating a new drug which has been specifically enginee=
red to be  biosimilar to Herceptin so that in effect it is considered the =
same drug. The drug called  DRL_TZ has been developed with the hope that i=
t will be a cheaper, equally safe and effective treatment option to Hercep=
tin(r) in treating these cancer types.  This study will investigate whethe=
r this new drug acts the same way in the body. If it is better than or at =
least equivalent to Herceptin, then it may enable people who need the medi=
cation to access it at a more affordable cost.
So far we have dosed 11 participants in this study and to date none have h=
ad any serious side effects as the drug we are testing is NOT chemotherapy=
.  Also, participants in this study are healthy and only receive one dose =
of the study drug whereas cancer patients=20receive chemotherapy in conjun=
ction with multiple doses of Herceptin.


Volunteers required:

*         Healthy males

*         Aged 18 - 55 years

*         BMI 18 - 30 and weigh 50-100 kg  inclusive

*         Non smokers

*         Not taking any medications


Study Duration

*          8 days & nights as an inpatient

*          7 outpatient visits


Our Location      Centre for Clinical Studies (AMREP Precinct Alfred Hospi=
tal) AMREP access map<http://clinicalstudies.com.au/wp-content/uploads/201=
4/02/AMREP-CCS-Access-MAP.pdf>
                                Level 5, 89 Commercial Road,
                                Melbourne, 3004.
                              Click here<https://maps.google.com.au/maps?q=
=3D89+commercial+road+melbourne+3004&ie=3DUTF-8&hq=3D&hnear=3D0x6ad6682290=
2afed9:0xca1cf794638a5956,85-89+Commercial+Rd,+Melbourne+VIC+3004&gl=3Dau&=
ei=3DrwD8UqTNL4GRkwX88YH4Aw&ved=3D0CCYQ8gEwAA> for the Google map.

Reimbursement:  $2,555 (Partial payment of $1000 on completion of Day 36)

Study Schedule:
Note: Participants will also need to attend for an Echocardiogram on eithe=
r on the 4th or 5th of April
Study Day

Date

Time

Comments

On Study

Day -1

Wednesday, 6 April 2016

14:00

Check-in

Day 8

Thursday, 14 April 2016

~10am

Check-out

Outpatient

Day 15

Thursday, 21 April 2016

N/A

Outpatient

Day 22

Thursday, 28 April 2016

N/A

Outpatient

Day 29

Thursday, 5 May 2016

N/A

Outpatient

Day 36

Thursday, 12 May 2016

N/A

Outpatient

Day 50

Thursday, 26 May 2016

N/A

Outpatient

Day 64

Thursday, 9 June 2016

N/A

Outpatient

Final Visit

Day 78

Thursday, 23 June 2016

N/A

Outpatient


Please also visit our website at www.clinicalstudies.com.au<http://www.cli=
nicalstudies.com.au>

If you do not wish to receive any further emails from us then please reply=
 to this email with the word 'unsubscribe' in the subject box.


Thanking you again for your interest.



Kind Regards



Natalie Bakota

Natalie Bakota|Senior Recruitment Officer| Centre for Clinical Studies |
Office: | Level 5 Burnet Institute | AMREP Precinct | 89 Commercial Road |=
 Victoria 3004 | Australia
T: | t: 03 9076 8957 | Reception: 03 9076 8900
N.Bakota@nucleusnetwork.com.au<mailto:N.Bakota@nucleusnetwork.com.au>   ww=
w.clinicalstudies.com.au<http://www.clinicalstudies.com.au/>
1800 243 733
Nucleus Network, Australia's Clinical Research Centre, operates in associa=
tion with Centre for Clinical Studies, Clinical Trials Consulting and its =
network partners

[See full size image]<http://www.facebook.com/pages/Centre-for-Clinical-St=
udies/199371513417842> You can now follow us on Facebook



______________________________________________________________________
This email has been scanned by the Symantec Email Security.cloud service.
For more information please visit http://www.symanteccloud.com
______________________________________________________________________
--_000_43607F02F7F979429DE2661B9FCBF6DFB5EDF140PRNEX2010nucleu_
Content-Type: text/html; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-mic=
rosoft-com:office:office" xmlns:w=3D"urn:schemas-microsoft-com:office:word=
" xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" xmlns=3D"ht=
tp://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dus-ascii=
">
<meta name=3D"Generator" content=3D"Microsoft Word 12 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
=09{font-family:"Cambria Math";
=09panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
=09{font-family:Calibri;
=09panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
=09{font-family:Tahoma;
=09panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
=09{font-family:Verdana;
=09panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
=09{font-family:Consolas;
=09panose-1:2 11 6 9 2 2 4 3 2 4;}
@font-face
=09{font-family:"Edwardian Script ITC";
=09panose-1:3 3 3 2 4 7 7 13 8 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
=09{margin:0cm;
=09margin-bottom:.0001pt;
=09font-size:11.0pt;
=09font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
=09{mso-style-priority:99;
=09color:blue;
=09text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
=09{mso-style-priority:99;
=09color:purple;
=09text-decoration:underline;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
=09{mso-style-priority:99;
=09mso-style-link:"Plain Text Char";
=09margin:0cm;
=09margin-bottom:.0001pt;
=09font-size:10.5pt;
=09font-family:Consolas;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
=09{mso-style-priority:99;
=09mso-style-link:"Balloon Text Char";
=09margin:0cm;
=09margin-bottom:.0001pt;
=09font-size:8.0pt;
=09font-family:"Tahoma","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
=09{mso-style-priority:34;
=09margin-top:0cm;
=09margin-right:0cm;
=09margin-bottom:0cm;
=09margin-left:36.0pt;
=09margin-bottom:.0001pt;
=09font-size:11.0pt;
=09font-family:"Calibri","sans-serif";}
span.PlainTextChar
=09{mso-style-name:"Plain Text Char";
=09mso-style-priority:99;
=09mso-style-link:"Plain Text";
=09font-family:Consolas;}
span.BalloonTextChar
=09{mso-style-name:"Balloon Text Char";
=09mso-style-priority:99;
=09mso-style-link:"Balloon Text";
=09font-family:"Tahoma","sans-serif";}
p.Default, li.Default, div.Default
=09{mso-style-name:Default;
=09margin:0cm;
=09margin-bottom:.0001pt;
=09text-autospace:none;
=09font-size:12.0pt;
=09font-family:"Verdana","sans-serif";
=09color:black;}
span.EmailStyle23
=09{mso-style-type:personal;
=09font-family:"Calibri","sans-serif";
=09color:windowtext;}
span.EmailStyle24
=09{mso-style-type:personal;
=09font-family:"Calibri","sans-serif";
=09color:#1F497D;}
span.EmailStyle25
=09{mso-style-type:personal;
=09font-family:"Calibri","sans-serif";
=09color:#1F497D;}
span.EmailStyle26
=09{mso-style-type:personal;
=09font-family:"Calibri","sans-serif";
=09color:#1F497D;}
span.EmailStyle27
=09{mso-style-type:personal;
=09font-family:"Calibri","sans-serif";
=09color:#1F497D;}
span.EmailStyle28
=09{mso-style-type:personal;
=09font-family:"Calibri","sans-serif";
=09color:#1F497D;}
span.EmailStyle29
=09{mso-style-type:personal;
=09font-family:"Calibri","sans-serif";
=09color:#1F497D;}
span.EmailStyle30
=09{mso-style-type:personal;
=09font-family:"Calibri","sans-serif";
=09color:#1F497D;}
span.EmailStyle31
=09{mso-style-type:personal-reply;
=09font-family:"Calibri","sans-serif";
=09color:#1F497D;}
.MsoChpDefault
=09{mso-style-type:export-only;
=09font-size:10.0pt;}
@page WordSection1
=09{size:612.0pt 792.0pt;
=09margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
=09{page:WordSection1;}
/* List Definitions */
@list l0
=09{mso-list-id:1381248752;
=09mso-list-type:hybrid;
=09mso-list-template-ids:1206829906 201916417 201916419 201916421 20191641=
7 201916419 201916421 201916417 201916419 201916421;}
@list l0:level1
=09{mso-level-number-format:bullet;
=09mso-level-text:\F0B7;
=09mso-level-tab-stop:none;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;
=09font-family:Symbol;}
@list l0:level2
=09{mso-level-tab-stop:72.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level3
=09{mso-level-tab-stop:108.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level4
=09{mso-level-tab-stop:144.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level5
=09{mso-level-tab-stop:180.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level6
=09{mso-level-tab-stop:216.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level7
=09{mso-level-tab-stop:252.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level8
=09{mso-level-tab-stop:288.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level9
=09{mso-level-tab-stop:324.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l1
=09{mso-list-id:1620533021;
=09mso-list-type:hybrid;
=09mso-list-template-ids:-2132772280 201916417 201916419 201916421 2019164=
17 201916419 201916421 201916417 201916419 201916421;}
@list l1:level1
=09{mso-level-number-format:bullet;
=09mso-level-text:\F0B7;
=09mso-level-tab-stop:none;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;
=09font-family:Symbol;}
@list l1:level2
=09{mso-level-tab-stop:72.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l1:level3
=09{mso-level-tab-stop:108.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l1:level4
=09{mso-level-tab-stop:144.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l1:level5
=09{mso-level-tab-stop:180.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l1:level6
=09{mso-level-tab-stop:216.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l1:level7
=09{mso-level-tab-stop:252.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l1:level8
=09{mso-level-tab-stop:288.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l1:level9
=09{mso-level-tab-stop:324.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
ol
=09{margin-bottom:0cm;}
ul
=09{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang=3D"EN-AU" link=3D"blue" vlink=3D"purple">
<div class=3D"WordSection1">
<p class=3D"MsoNormal">Hello<span style=3D"color:#1F497D"> </span>Everyone=
<o:p></o:p></p>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US">Here is a new study and a very=
 important one.
<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US">Although the study may not see=
m as appealing to you because it requires 8 outpatient visits, we believe =
in the cause as hundreds of thousands of women still die each year from br=
east cancer and the currently available
 drug used to treat some of the breast and/or gastric cancers is very expe=
nsive and therefore inaccessible to some women</span>.
<o:p></o:p></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal"><span style=3D"color:#7030A0">&nbsp;<o:p></o:p></sp=
an></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center"><sp=
an style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sans-se=
rif&quot;;color:purple">If you are interested in participating in the stud=
y then please send us a return email or contact us on
</span><b><span style=3D"font-size:16.0pt;font-family:&quot;Calibri&quot;,=
&quot;sans-serif&quot;;color:purple">1800 243 733</span></b><span style=3D=
"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;;c=
olor:purple"> as we will need to phone screen you and organise a screening=
 appointment
 (medical check up).&nbsp; <o:p></o:p></span></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center"><b>=
<span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sans=
-serif&quot;;color:purple">Please note that we will be screening participa=
nts from Thursday 31<sup>st</sup> March to Monday 4<sup>th</sup>
 April <o:p></o:p></span></b></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center;text=
-indent:36.0pt">
<b><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;s=
ans-serif&quot;">YOU NEED TO CALL/EMAIL TO MAKE AN APPOINTMENT. NO WALK-IN=
S.<o:p></o:p></span></b></p>
<p class=3D"MsoPlainText" align=3D"center" style=3D"text-align:center;text=
-indent:36.0pt">
<b><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;s=
ans-serif&quot;;color:#3333CC"><o:p>&nbsp;</o:p></span></b></p>
<p class=3D"MsoNormal"><b>TZ-01-003</b>:&nbsp; Breast and gastric cancers =
are two of the biggest causes of death from cancer in Australia and worldw=
ide. Trastuzumab, which is marketed in Australia and nearly worldwide as H=
erceptin&reg;, has been considerably successful
 in treating these life-threatening conditions over the last 15 years. Alt=
hough not a cure in itself, it has been shown to substantially slow the ca=
ncer growth and thereby extend the lives of cancer sufferers. &nbsp;<span =
style=3D"color:#1F497D"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal">This study is investigating a new drug which has be=
en specifically engineered to be &nbsp;biosimilar to<b>
</b>Herceptin so that in effect it is considered the same drug. The drug c=
alled &nbsp;DRL_TZ has been developed with the hope that it will be a chea=
per, equally safe and effective treatment option to Herceptin&reg; in trea=
ting these cancer types.&nbsp; This study will investigate
 whether this new drug acts the same way in the body. If it is better than=
 or at least equivalent to Herceptin, then it may enable people who need t=
he medication to access it at a more affordable cost.
<o:p></o:p></p>
<p class=3D"MsoNormal"><span style=3D"color:#3333CC">So far we have dosed =
11 participants in this study and to date none have had any serious side e=
ffects as the drug we are testing is
<b>NOT chemotherapy</b>.&nbsp; Also, participants in this study are health=
y and only receive one dose of the study drug whereas cancer patients rece=
ive chemotherapy in conjunction with multiple doses of Herceptin.
<o:p></o:p></span></p>
<p class=3D"Default"><span style=3D"font-size:11.0pt;font-family:&quot;Cal=
ibri&quot;,&quot;sans-serif&quot;;color:windowtext"><o:p>&nbsp;</o:p></spa=
n></p>
<p class=3D"MsoNormal"><b>Volunteers required: </b><o:p></o:p></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt;mso-list:l0 lev=
el1 lfo2"><![if !supportLists]><span style=3D"font-family:Symbol"><span st=
yle=3D"mso-list:Ignore">&middot;<span style=3D"font:7.0pt &quot;Times New =
Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Healthy males<o:p></o:p></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt;mso-list:l0 lev=
el1 lfo2"><![if !supportLists]><span style=3D"font-family:Symbol"><span st=
yle=3D"mso-list:Ignore">&middot;<span style=3D"font:7.0pt &quot;Times New =
Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Aged 18 &#8211; 55 years <o:p></o:p></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt;mso-list:l0 lev=
el1 lfo2"><![if !supportLists]><span style=3D"font-family:Symbol"><span st=
yle=3D"mso-list:Ignore">&middot;<span style=3D"font:7.0pt &quot;Times New =
Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>BMI 18 &#8211; 30 and weigh 50-100 kg &nbsp=
;inclusive<o:p></o:p></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt;mso-list:l0 lev=
el1 lfo2"><![if !supportLists]><span style=3D"font-family:Symbol"><span st=
yle=3D"mso-list:Ignore">&middot;<span style=3D"font:7.0pt &quot;Times New =
Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Non smokers <o:p></o:p></p>
<p class=3D"MsoListParagraph" style=3D"text-indent:-18.0pt;mso-list:l0 lev=
el1 lfo2"><![if !supportLists]><span style=3D"font-family:Symbol"><span st=
yle=3D"mso-list:Ignore">&middot;<span style=3D"font:7.0pt &quot;Times New =
Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Not taking any medications <o:p></o:p></p>
<p class=3D"MsoNormal">&nbsp;<o:p></o:p></p>
<p class=3D"MsoPlainText"><b><span style=3D"font-size:11.0pt;font-family:&=
quot;Calibri&quot;,&quot;sans-serif&quot;">Study Duration</span></b><o:p><=
/o:p></p>
<p class=3D"MsoPlainText" style=3D"margin-left:36.0pt;text-indent:-18.0pt;=
mso-list:l1 level1 lfo4">
<![if !supportLists]><span style=3D"font-family:Symbol"><span style=3D"mso=
-list:Ignore">&middot;<span style=3D"font:7.0pt &quot;Times New Roman&quot=
;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D"font-size:11.0pt;font-family=
:&quot;Calibri&quot;,&quot;sans-serif&quot;">&nbsp;8 days &amp; nights as =
an inpatient
</span><o:p></o:p></p>
<p class=3D"MsoPlainText" style=3D"margin-left:36.0pt;text-indent:-18.0pt;=
mso-list:l1 level1 lfo4">
<![if !supportLists]><span style=3D"font-family:Symbol"><span style=3D"mso=
-list:Ignore">&middot;<span style=3D"font:7.0pt &quot;Times New Roman&quot=
;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D"font-size:11.0pt;font-family=
:&quot;Calibri&quot;,&quot;sans-serif&quot;">&nbsp;7 outpatient visits</sp=
an><o:p></o:p></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;">&nbsp;</span><o:p></o:p></p>
<p class=3D"MsoNormal"><b>Our Location</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C=
entre for Clinical Studies (AMREP Precinct Alfred Hospital)
<a href=3D"http://clinicalstudies.com.au/wp-content/uploads/2014/02/AMREP-=
CCS-Access-MAP.pdf">
<span style=3D"color:windowtext">AMREP access map</span></a><o:p></o:p></p=
>
<p class=3D"MsoNormal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Level 5, 89 Comme=
rcial Road,
<o:p></o:p></p>
<p class=3D"MsoNormal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Melbourne, 3004.<=
o:p></o:p></p>
<p class=3D"MsoNormal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Click <a href=3D"https://maps.goog=
le.com.au/maps?q=3D89&#43;commercial&#43;road&#43;melbourne&#43;3004&amp;i=
e=3DUTF-8&amp;hq=3D&amp;hnear=3D0x6ad66822902afed9:0xca1cf794638a5956,85-8=
9&#43;Commercial&#43;Rd,&#43;Melbourne&#43;VIC&#43;3004&amp;gl=3Dau&amp;ei=
=3DrwD8UqTNL4GRkwX88YH4Aw&amp;ved=3D0CCYQ8gEwAA">
<span style=3D"color:windowtext">here</span></a> for the <b>Google map</b>=
.<o:p></o:p></p>
<p class=3D"MsoNormal"><b>&nbsp;</b><o:p></o:p></p>
<p class=3D"MsoNormal"><b>Reimbursement</b>: &nbsp;<b><span style=3D"font-=
size:12.0pt">$2,555 (Partial payment of $1000 on completion of Day 36)</sp=
an></b><o:p></o:p></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#1F497D">&nbsp;</span></b><=
o:p></o:p></p>
<p class=3D"MsoNormal"><b>Study Schedule: <o:p></o:p></b></p>
<p class=3D"MsoNormal"><b>Note: Participants will also need to attend for =
an Echocardiogram on either<span style=3D"color:black"> on the 4<sup>th</s=
up> or 5<sup>th</sup> of April</span><span style=3D"color:#1F497D"><o:p></=
o:p></span></b></p>
<table class=3D"MsoNormalTable" border=3D"0" cellspacing=3D"0" cellpadding=
=3D"0" width=3D"645" style=3D"width:484.0pt;margin-left:-1.15pt;border-col=
lapse:collapse">
<tbody>
<tr style=3D"height:15.75pt">
<td width=3D"215" nowrap=3D"" colspan=3D"2" valign=3D"bottom" style=3D"wid=
th:161.0pt;border:solid windowtext 1.0pt;background:#F2F2F2;padding:0cm 5.=
4pt 0cm 5.4pt;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:black">Study Day<o:p></o:p></span></b></p>
</td>
<td width=3D"228" nowrap=3D"" style=3D"width:171.0pt;border:solid windowte=
xt 1.0pt;border-left:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;h=
eight:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:black">Date<o:p></o:p></span></b></p>
</td>
<td width=3D"88" nowrap=3D"" style=3D"width:66.0pt;border:solid windowtext=
 1.0pt;border-left:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;hei=
ght:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:black">Time<o:p></o:p></span></b></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border:solid windowtex=
t 1.0pt;border-left:none;background:#F2F2F2;padding:0cm 5.4pt 0cm 5.4pt;he=
ight:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:black">Comments<o:p></o:p></span></b></p>
</td>
</tr>
<tr style=3D"height:19.5pt">
<td width=3D"92" nowrap=3D"" rowspan=3D"2" style=3D"width:69.25pt;border:s=
olid windowtext 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt=
 0cm 5.4pt;height:19.5pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:black">On Study<o:p></o:p></span></b></p>
</td>
<td width=3D"122" nowrap=3D"" valign=3D"bottom" style=3D"width:91.75pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#F1F79F;padding:0cm 5.4pt 0cm 5.4p=
t;height:19.5pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Day -1=
<o:p></o:p></p>
</td>
<td width=3D"228" nowrap=3D"" valign=3D"bottom" style=3D"width:171.0pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#F1F79F;padding:0cm 5.4pt 0cm 5.4p=
t;height:19.5pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><span =
style=3D"color:black">Wednesday, 6 April 2016</span><o:p></o:p></p>
</td>
<td width=3D"88" nowrap=3D"" valign=3D"bottom" style=3D"width:66.0pt;borde=
r-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-ri=
ght:solid windowtext 1.0pt;background:#F1F79F;padding:0cm 5.4pt 0cm 5.4pt;=
height:19.5pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">14:00<=
o:p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowt=
ext 1.0pt;background:#F1F79F;padding:0cm 5.4pt 0cm 5.4pt;height:19.5pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Check-=
in<o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:15.0pt">
<td width=3D"122" nowrap=3D"" valign=3D"bottom" style=3D"width:91.75pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#F1F79F;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Day 8<=
o:p></o:p></p>
</td>
<td width=3D"228" nowrap=3D"" valign=3D"bottom" style=3D"width:171.0pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#F1F79F;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><span =
style=3D"color:black">Thursday, 14 April 2016</span><o:p></o:p></p>
</td>
<td width=3D"88" nowrap=3D"" valign=3D"bottom" style=3D"width:66.0pt;borde=
r-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-ri=
ght:solid windowtext 1.0pt;background:#F1F79F;padding:0cm 5.4pt 0cm 5.4pt;=
height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">~10am<=
o:p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowt=
ext 1.0pt;background:#F1F79F;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Check-=
out<o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:15.0pt">
<td width=3D"92" nowrap=3D"" rowspan=3D"6" style=3D"width:69.25pt;border:s=
olid windowtext 1.0pt;border-top:none;background:#F2F2F2;padding:0cm 5.4pt=
 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:black">Outpatient<o:p></o:p></span></b></p>
</td>
<td width=3D"122" nowrap=3D"" valign=3D"bottom" style=3D"width:91.75pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Day 15=
<o:p></o:p></p>
</td>
<td width=3D"228" nowrap=3D"" valign=3D"bottom" style=3D"width:171.0pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><span =
style=3D"color:black">Thursday, 21 April 2016</span><o:p></o:p></p>
</td>
<td width=3D"88" nowrap=3D"" valign=3D"bottom" style=3D"width:66.0pt;borde=
r-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-ri=
ght:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4pt;=
height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">N/A<o:=
p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowt=
ext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Outpat=
ient<o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:15.0pt">
<td width=3D"122" nowrap=3D"" valign=3D"bottom" style=3D"width:91.75pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Day 22=
<o:p></o:p></p>
</td>
<td width=3D"228" nowrap=3D"" valign=3D"bottom" style=3D"width:171.0pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><span =
style=3D"color:black">Thursday, 28 April 2016</span><o:p></o:p></p>
</td>
<td width=3D"88" nowrap=3D"" valign=3D"bottom" style=3D"width:66.0pt;borde=
r-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-ri=
ght:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4pt;=
height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">N/A<o:=
p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowt=
ext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Outpat=
ient<o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:15.0pt">
<td width=3D"122" nowrap=3D"" valign=3D"bottom" style=3D"width:91.75pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Day 29=
<o:p></o:p></p>
</td>
<td width=3D"228" nowrap=3D"" valign=3D"bottom" style=3D"width:171.0pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><span =
style=3D"color:black">Thursday, 5 May 2016</span><o:p></o:p></p>
</td>
<td width=3D"88" nowrap=3D"" valign=3D"bottom" style=3D"width:66.0pt;borde=
r-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-ri=
ght:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4pt;=
height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">N/A<o:=
p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowt=
ext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Outpat=
ient<o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:14.45pt">
<td width=3D"122" nowrap=3D"" valign=3D"bottom" style=3D"width:91.75pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4p=
t;height:14.45pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Day 36=
<o:p></o:p></p>
</td>
<td width=3D"228" nowrap=3D"" valign=3D"bottom" style=3D"width:171.0pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4p=
t;height:14.45pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><span =
style=3D"color:black">Thursday, 12 May 2016</span><o:p></o:p></p>
</td>
<td width=3D"88" nowrap=3D"" valign=3D"bottom" style=3D"width:66.0pt;borde=
r-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-ri=
ght:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4pt;=
height:14.45pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">N/A<o:=
p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowt=
ext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4pt;height:14.45pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Outpat=
ient<o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:15.0pt">
<td width=3D"122" nowrap=3D"" valign=3D"bottom" style=3D"width:91.75pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Day 50=
<o:p></o:p></p>
</td>
<td width=3D"228" nowrap=3D"" valign=3D"bottom" style=3D"width:171.0pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><span =
style=3D"color:black">Thursday, 26 May 2016</span><o:p></o:p></p>
</td>
<td width=3D"88" nowrap=3D"" valign=3D"bottom" style=3D"width:66.0pt;borde=
r-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-ri=
ght:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4pt;=
height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">N/A<o:=
p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowt=
ext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Outpat=
ient<o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:15.0pt">
<td width=3D"122" nowrap=3D"" valign=3D"bottom" style=3D"width:91.75pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Day 64=
<o:p></o:p></p>
</td>
<td width=3D"228" nowrap=3D"" valign=3D"bottom" style=3D"width:171.0pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><span =
style=3D"color:black">Thursday, 9 June 2016</span><o:p></o:p></p>
</td>
<td width=3D"88" nowrap=3D"" valign=3D"bottom" style=3D"width:66.0pt;borde=
r-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-ri=
ght:solid windowtext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4pt;=
height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">N/A<o:=
p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowt=
ext 1.0pt;background:#E4C3F3;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Outpat=
ient<o:p></o:p></p>
</td>
</tr>
<tr style=3D"height:15.75pt">
<td width=3D"92" nowrap=3D"" valign=3D"bottom" style=3D"width:69.25pt;bord=
er:solid windowtext 1.0pt;border-top:none;background:#F8D7A6;padding:0cm 5=
.4pt 0cm 5.4pt;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><b><sp=
an style=3D"color:black">Final Visit<o:p></o:p></span></b></p>
</td>
<td width=3D"122" nowrap=3D"" valign=3D"bottom" style=3D"width:91.75pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#F8D7A6;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Day 78=
<o:p></o:p></p>
</td>
<td width=3D"228" nowrap=3D"" valign=3D"bottom" style=3D"width:171.0pt;bor=
der-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-=
right:solid windowtext 1.0pt;background:#F8D7A6;padding:0cm 5.4pt 0cm 5.4p=
t;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center"><span =
style=3D"color:black">Thursday, 23 June 2016</span><o:p></o:p></p>
</td>
<td width=3D"88" nowrap=3D"" valign=3D"bottom" style=3D"width:66.0pt;borde=
r-top:none;border-left:none;border-bottom:solid windowtext 1.0pt;border-ri=
ght:solid windowtext 1.0pt;background:#F8D7A6;padding:0cm 5.4pt 0cm 5.4pt;=
height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">N/A<o:=
p></o:p></p>
</td>
<td width=3D"115" nowrap=3D"" style=3D"width:86.0pt;border-top:none;border=
-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowt=
ext 1.0pt;background:#F8D7A6;padding:0cm 5.4pt 0cm 5.4pt;height:15.75pt">
<p class=3D"MsoNormal" align=3D"center" style=3D"text-align:center">Outpat=
ient<o:p></o:p></p>
</td>
</tr>
</tbody>
</table>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal"><span style=3D"color:black">Please also visit our w=
ebsite at <a href=3D"http://www.clinicalstudies.com.au">
<span style=3D"color:black">www.clinicalstudies.com.au</span></a> <o:p></o=
:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#1F497D">&nbsp;</span></b><=
o:p></o:p></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#C00000">If you do not wish=
 to receive any further emails from us then please reply to this email wit=
h the word &#8216;unsubscribe&#8217; in the subject box.</span></b><o:p></=
o:p></p>
<p class=3D"MsoNormal">&nbsp;<o:p></o:p></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;">Thanking you again for your intere=
st.<span style=3D"color:#1F497D">
</span><o:p></o:p></span></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;;color:#1F497D"><o:p>&nbsp;</o:p></s=
pan></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;">Kind Regards<o:p></o:p></span></p>=

<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:22.0pt;font-family:&quo=
t;Edwardian Script ITC&quot;;color:#1F497D">Natalie Bakota<o:p></o:p></spa=
n></b></p>
<p class=3D"MsoNormal"><span style=3D"font-family:&quot;Arial&quot;,&quot;=
sans-serif&quot;;color:#1F497D"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D">Natalie Bakota|Senior=
 Recruitment Officer|
</span><b><span style=3D"color:#00B0F0">Centre for Clinical Studies</span>=
</b><span style=3D"color:#99CC00">
</span><span style=3D"color:#1F497D">|&nbsp;<br>
Office: | Level 5 Burnet Institute | AMREP Precinct | 89 Commercial Road |=
&nbsp;Victoria 3004 | Australia<br>
T: |&nbsp;t: 03 9076 8957 |&nbsp;Reception: 03 9076 8900 <o:p></o:p></span=
></p>
<p class=3D"MsoNormal"><b><u><span lang=3D"FR" style=3D"color:#00B0F0"><a =
href=3D"mailto:N.Bakota@nucleusnetwork.com.au"><span style=3D"color:#00B0F=
0">N.Bakota@nucleusnetwork.com.au</span></a></span></u></b><b><span lang=3D=
"FR" style=3D"color:#00B0F0">&nbsp;&nbsp;
<a href=3D"http://www.clinicalstudies.com.au/"><span style=3D"color:#00B0F=
0">www.clinicalstudies.com.au</span></a><o:p></o:p></span></b></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:16.0pt;color:#1F497D">1=
800 243 733</span></b><b><span style=3D"font-size:16.0pt;color:#00B0F0"><o=
:p></o:p></span></b></p>
<p class=3D"MsoNormal"><b><i><span style=3D"color:#1F497D">Nucleus Network=
, Australia's Clinical Research Centre, operates in association with Centr=
e for Clinical Studies, Clinical Trials Consulting and its network partner=
s</span></i></b><span style=3D"color:#1F497D"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal"><a href=3D"http://www.facebook.com/pages/Centre-for=
-Clinical-Studies/199371513417842"><span style=3D"color:#1F497D;text-decor=
ation:none"><img border=3D"0" width=3D"43" height=3D"43" id=3D"Picture_x00=
20_1" src=3D"cid:image001.jpg@01D18A72.D7F3A9B0" alt=3D"See full size imag=
e"></span></a><span style=3D"color:#1F497D">&nbsp;<b>You
 can now follow us on Facebook<o:p></o:p></b></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
</div>
<br clear=3D"both">
______________________________________________________________________<BR>=

This email has been scanned by the Symantec Email Security.cloud service.<=
BR>
For more information please visit http://www.symanteccloud.com<BR>
______________________________________________________________________<BR>=

</body>
</html>

--_000_43607F02F7F979429DE2661B9FCBF6DFB5EDF140PRNEX2010nucleu_--

--_004_43607F02F7F979429DE2661B9FCBF6DFB5EDF140PRNEX2010nucleu_
Content-Type: image/jpeg; name="image001.jpg"
Content-Description: image001.jpg
Content-Disposition: inline; filename="image001.jpg"; size=1251;
	creation-date="Tue, 29 Mar 2016 23:56:42 GMT";
	modification-date="Tue, 29 Mar 2016 23:56:42 GMT"
Content-ID: <image001.jpg@01D18A72.D7F3A9B0>
Content-Transfer-Encoding: base64
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--_004_43607F02F7F979429DE2661B9FCBF6DFB5EDF140PRNEX2010nucleu_--
